NBIX
Neurocrine Biosciences Inc
$127.78
-1.36% ($1.76)
Volume
793,135
52W High
$160.18
52W Low
$84.23
Market Cap
$13.72B
What to Watch This Quarter
Based on historical dataConsensus EPS
$1.42
Whisper EPS
$1.43
0.5% above consensus
Last Quarter
$1.88
Current Streak
3 Beats
Avg Surprise (4Q)
-5.22%
Next Earnings Report
Reports in 53 days
Price Chart
EPS History: Consensus vs Actual
Last 12 quartersPrice Movement Around Earnings
Q4 2025
Feb 11, 2026
1-Day:
-10.43%
Q3 2025
Oct 30, 2025
1-Day:
+3.75%
5-Day:
+3.73%
Q2 2025
Jul 30, 2025
1-Day:
-6.24%
5-Day:
-6.38%
Q1 2025
May 5, 2025
1-Day:
+8.36%
Revenue & Financial Performance
Revenue Whisper
$769.0M
TWN Proprietary Estimate
Last Quarter Revenue
$805.5M
+28.3% YoY
Gross Margin
97.8%
Net Margin: 19.1%
| Quarter | Revenue | YoY Growth | Gross Margin | Op Margin | Net Income |
|---|---|---|---|---|---|
| Q4'25 | $805.5M | +28.3% | 97.8% | 26.2% | $153.7M |
| Q3'25 | $794.9M | +27.8% | 98.2% | 30.1% | $209.5M |
| Q2'25 | $687.5M | +16.5% | 98.4% | 21.2% | $107.5M |
| Q1'25 | $572.6M | +11.1% | 98.4% | 4.1% | $7.9M |
| Q4'24 | $627.7M | +21.8% | 98.5% | 22.6% | $103.1M |
| Q3'24 | $622.1M | +24.7% | 98.7% | 29.6% | $129.8M |
| Q2'24 | $590.2M | +30.4% | 98.4% | 24.6% | $65.0M |
| Q1'24 | $515.3M | +22.6% | 98.5% | 19.3% | $43.4M |
Company Information
Symbol
NBIX
Company
Neurocrine Biosciences Inc
Market Cap
$13.72B
Next Earnings
May 6, 2026